StockData
Lantern Pharma Inc. logo

Lantern Pharma Inc. (LTRN) stock

LTRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 5/30
$0.33−0.04 (-9.78%)

Close on Nov 18, 2026Market cap $4.21MP/E –Yield –

Lantern Pharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Lantern Pharma's market cap was $6.14M on Nov 11, 2026, against $39.97M a year earlier. Over the last 5 years it ranged from $6.14M to $94.35M, with a median of $46.52M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.14M-81.7%
2025Dec 31, 2025$33.45M-2.8%
2024Dec 31, 2024$34.40M-26.0%
2023Dec 29, 2023$46.52M-29.1%
2022Dec 30, 2022$65.58M-26.5%
2021Dec 31, 2021$89.27M-25.4%
2020Dec 31, 2020$119.69M–

More Lantern Pharma figures

See a number that looks wrong?